Investor Relations Portals - BB BIOTECH VENTURES

Relaunch des  Investor Relations Portal von BB BIOTECH VENTURES. Digital Werkstatt übernahm das Design, die Content-Konzeption und die Erstellung der Content Management fähigen Templates. Dieses Projekt ist eine Gemeinschaftsproduktion mit coolscreen.de. Unser Partner für eCMS (Enterprice Content Management Systems). Dieser Internetauftritt wurde mit dem eCMS von eZ Systems [ http://ez.no ] realisiert.

BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices. The Guernsey–based fund is advised by the Swissfirst Asset Management Group (formerly Bellevue Asset Management), which has operations in Boston and Kusnacht/Zurich, Switzerland. BB BIOTECH VENTURES currently invests from Fund II, which has a size of USD 123 mn and was closed in 2005.

The Management Team consists of three professionals and is supported by a dedicated Advisory Board. In addition, the team has access to all resources of the Group’s large healthcare investment franchise, and to an extensive network of specialists and advisors.